May 23, 2023 Team Rxtrospect FDA Approves AYVAKIT (avapritinib) as the First and Only Treatment for Indolent Systemic Mastocytosis May 23, 2023 Team Rxtrospect SCHEDULE A DEMO Team Rxtrospect